Abstract Details
|
Alexandra Rubenstein
(Boston Medical Center)
PRESENTER |
Miss Rubenstein has nothing to disclose. |
| Rebecca Stafford (Boston Medical Center) | Ms. Stafford has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| Carolina B. Maciel, MD, MSCR, FAAN | Dr. Maciel has received research support from American Heart Association. Dr. Maciel has received research support from National Institute of Health. |
| No disclosure on file | |
| No disclosure on file | |
| Rachel Beekman, MD (Yale New Haven Medical Center) | Dr. Beekman has nothing to disclose. |
| Emily J. Gilmore, MD (Yale University School of Medicine) | Dr. Gilmore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for carpl.ai. Dr. Gilmore has received personal compensation in the range of $0-$499 for serving as a Consultant for AAN. Dr. Gilmore has received research support from NIH. |
| David M. Greer, MD, FAAN (Boston University School of Medicine) | Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. An immediate family member of Dr. Greer has or had stock in Vertex Pharmaceuticals. The institution of Dr. Greer has received research support from NINDS. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities. |